Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

被引：4
|
作者：
Poynard, T [1 ]
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris, France
来源：
GUT | 2003年 / 52卷 / 10期
关键词：
D O I：
10.1136/gut.52.10.1532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1532 / 1532
页数：1
相关论文
共 50 条
  • [31] Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C
    Yamashita, Naoki
    Enjoji, Munechika
    Kotoh, Kazuhiro
    Kato, Masaki
    Ueda, Akihiro
    Horikawa, Yuki
    Tajiri, Hirotaka
    Higuchi, Nobito
    Kinukawa, Naoko
    Nakamuta, Makoto
    Takayanagi, Ryoichi
    JOURNAL OF DIGESTIVE DISEASES, 2008, 9 (01) : 27 - 31
  • [32] Combination therapy with pegylated interferon-A 2b and ribavirin in naive patients with chronic hepatitis C virus inection.
    Kallinowski, B
    Engler, S
    Bauer, E
    Stremmel, W
    Rossol, S
    HEPATOLOGY, 2002, 36 (04) : 580A - 580A
  • [33] New-Onset Psoriasis Following Treatment with Pegylated Interferon-Alpha 2b and Ribavirin for Chronic Hepatitis C
    Horev, Amir
    Halevy, Sima
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (12): : 760 - 761
  • [34] Ribavirin in combination with alpha-2b interferon for the treatment of chronic hepatitis C
    Hillon, P
    PRESSE MEDICALE, 2001, 30 (07): : 335 - 336
  • [35] Effectiveness of Interferon α-2b and Ribavirin Combination Therapy in the Treatment of Naive Chronic Hepatitis C Patients in Clinical Practice
    Shehab, Thomas M.
    Fontana, Robert J.
    Oberhelman, Kelly
    Marrero, Jorge A.
    Su, Grace L.
    Lok, Anna S. F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (05) : 425 - 431
  • [36] Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Midha, Vandana
    Sood, Ajit
    Syed, Hissar
    Sood, Neena
    Kumar, Manoj
    Sarin, Shiv K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A13 - A13
  • [37] Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C : the PegIntrust Study
    Van Vlierberghe, H.
    Adler, M.
    Bastens, B.
    Colle, I.
    Delwaide, J.
    Henrion, J.
    Horsmans, Y.
    Michielsen, P.
    Golstein, P.
    Mulkays, J. -P.
    Van Steenbergen, W.
    Yap, P.
    Nevens, F.
    Denys, A. M.
    Brasseur, J. -P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (01) : 5 - 11
  • [38] The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
    Hiroki Nishikawa
    Eriko Iguchi
    Yorimitsu Koshikawa
    Soichiro Ako
    Tadashi Inuzuka
    Haruhiko Takeda
    Jun Nakajima
    Fumihiro Matsuda
    Azusa Sakamoto
    Sinichiro Henmi
    Keiichi Hatamaru
    Tetsuro Ishikawa
    Sumio Saito
    Ryuichi Kita
    Toru Kimura
    Yukio Osaki
    BMC Research Notes, 5 (1)
  • [39] Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.
    Wong, JB
    Siebert, U
    Manns, MP
    McHutchison, JG
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Rossol, S
    Ling, MH
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
  • [40] Viusid, a nutritional supplement, in combination with interferon α-2b and ribavirin in patients with chronic hepatitis C
    Gomez, Eduardo Vilar
    Oramas, Bienvenido Gra
    Soler, EnriqueArus
    Navarro, Raimundo Llanio
    Domech, Caridad Ruenes
    LIVER INTERNATIONAL, 2007, 27 (02) : 247 - 259
12345